NLRC4-/- mice with NAFLD also had decreased TAMs and decreased IL-1β and VEGF expression, suggesting that NLRC4 plays a key role in the growth and recurrence of liver metastases in the context of both NAFLD and colorectal cancer (62) (Figure 3E). This evidence concerns the gene NLRC4 and metabolic dysfunction-associated steatotic liver disease.